{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:06:03Z","timestamp":1779253563943,"version":"3.51.4"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Ministry of Higher Education and Scientific Research, Tunisia","award":["LR16IPT\/05"],"award-info":[{"award-number":["LR16IPT\/05"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]},{"name":"Projet collaboratif interne Institut pasteur de Tunis","award":["PCI Melanoma 2012"],"award-info":[{"award-number":["PCI Melanoma 2012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15966-8","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:05:58Z","timestamp":1775797558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological and molecular characterization of tumor-associated macrophages in sporadic and Xeroderma Pigmentosum-related cutaneous melanoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Asma","family":"Chikhaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Tounsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Nabouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Jenni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika Ben","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chokri","family":"Naouali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Zghal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamida","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-4775","authenticated-orcid":false,"given":"Houda","family":"Yacoub-Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"1","key":"15966_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"15966_CR2","doi-asserted-by":"crossref","unstructured":"Kouki C, Sellami K, Souissi A, Hammami H, Jones M, Mokni M et al. Le m\u00e9lanome en Tunisie: \u00e9tude multicentrique. Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie - FMC. 2023;3(8):A169-A70.","DOI":"10.1016\/j.fander.2023.09.313"},{"issue":"1","key":"15966_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1172-6-70","volume":"6","author":"AR Lehmann","year":"2011","unstructured":"Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6(1):70.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"15966_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ajhb.22764","volume":"28","author":"N Ben Halim","year":"2016","unstructured":"Ben Halim N, Hsouna S, Lasram K, Rejeb I, Walha A, Talmoudi F, et al. Differential impact of consanguineous marriages on autosomal recessive diseases in Tunisia. Am J Hum Biol. 2016;28(2):171\u201380.","journal-title":"Am J Hum Biol"},{"key":"15966_CR5","doi-asserted-by":"publisher","first-page":"810058","DOI":"10.3389\/fonc.2022.810058","volume":"12","author":"S Fischer","year":"2022","unstructured":"Fischer S, Hamed M, Emmert S, Wolkenhauer O, Fuellen G, Thiem A. The prognostic and predictive role of xeroderma pigmentosum gene expression in melanoma. Front Oncol. 2022;12:810058.","journal-title":"Front Oncol"},{"key":"15966_CR6","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","volume":"9","author":"SD Jayasingam","year":"2020","unstructured":"Jayasingam SD, Citartan M, Thang TH, Mat Zin AA, Ang KC, Ch\u2019ng ES. Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice. Front Oncol. 2020;9:1512.","journal-title":"Front Oncol"},{"key":"15966_CR7","doi-asserted-by":"publisher","first-page":"583084","DOI":"10.3389\/fimmu.2020.583084","volume":"11","author":"Y Pan","year":"2020","unstructured":"Pan Y, Yu Y, Wang X, Zhang T. Tumor-associated macrophages in tumor immunity. Front Immunol. 2020;11:583084.","journal-title":"Front Immunol"},{"issue":"9","key":"15966_CR8","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340.","journal-title":"J Cell Physiol"},{"issue":"5","key":"15966_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","volume":"53","author":"AA Tarique","year":"2015","unstructured":"Tarique AA, Logan J, Thomas E, Holt PG, Sly PD, Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am J Respir Cell Mol Biol. 2015;53(5):676\u201388.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"15966_CR10","doi-asserted-by":"crossref","unstructured":"Aldo PB, Craveiro V, Guller S, Mor G. Effect of culture conditions on the phenotype of THP-1 monocyte cell line. Wiley Online Library; 2013. p. 1046\u20137408.","DOI":"10.1111\/aji.12129"},{"key":"15966_CR11","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1007\/s00018-019-03413-w","volume":"77","author":"M Werner","year":"2020","unstructured":"Werner M, Pace S, Czapka A, Jordan PM, Gerstmeier J, Koeberle A, et al. Communication between human macrophages and epithelial cancer cell lines dictates lipid mediator biosynthesis. Cell Mol Life Sci. 2020;77:4365\u201378.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"15966_CR12","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.4049\/jimmunol.181.6.3733","volume":"181","author":"M Benoit","year":"2008","unstructured":"Benoit M, Desnues B, Mege J-L. Macrophage polarization in bacterial infections. J Immunol. 2008;181(6):3733\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"15966_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","volume":"9","author":"S Sanjabi","year":"2009","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009;9(4):447\u201353.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"15966_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12958-022-00983-6","volume":"20","author":"TS Martins","year":"2022","unstructured":"Martins TS, Fonseca BM, Rebelo I. The role of macrophages phenotypes in the activation of resolution pathways within human granulosa cells. Reproductive Biology Endocrinol. 2022;20(1):116.","journal-title":"Reproductive Biology Endocrinol"},{"issue":"3","key":"15966_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s13770-021-00414-4","volume":"19","author":"C Savitri","year":"2022","unstructured":"Savitri C, Kwon JW, Drobyshava V, Ha SS, Park K. M2 macrophage-derived concentrated conditioned media significantly improves skin wound healing. Tissue Eng Regenerative Med. 2022;19(3):617\u201328.","journal-title":"Tissue Eng Regenerative Med"},{"key":"15966_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0622-0","volume":"7","author":"B Benner","year":"2019","unstructured":"Benner B, Scarberry L, Suarez-Kelly LP, Duggan MC, Campbell AR, Smith E, et al. Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro. J Immunother Cancer. 2019;7:1\u201314.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"15966_CR17","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1038\/s41598-022-17928-z","volume":"12","author":"A Chikhaoui","year":"2022","unstructured":"Chikhaoui A, Jones M, Re\u017een T, Ben Ahmed M, Naouali C, Komel R, et al. Inflammatory landscape in xeroderma pigmentosum patients with cutaneous melanoma. Sci Rep. 2022;12(1):13854.","journal-title":"Sci Rep"},{"issue":"4","key":"15966_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4103\/0377-4929.56149","volume":"52","author":"TN Rao","year":"2009","unstructured":"Rao TN, Bhagyalaxmi A, Ahmed K, Rao TM, Venkatachalam K. A case of melanoma in xeroderma pigmentosum. Indian J Pathol Microbiol. 2009;52(4):524\u20136.","journal-title":"Indian J Pathol Microbiol"},{"key":"15966_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2025.101615","author":"Thomas R Spitzer","year":"2025","unstructured":"Spitzer TR, Lazarus HM. Endogenous and exogenous cytokines: an overview and introduction. best practice & research clinical haematology. 2025:101615. https:\/\/doi.org\/10.1016\/j.beha.2025.101615.","journal-title":"Best Practice &amp; Research Clinical Haematology"},{"issue":"6","key":"15966_CR20","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s12276-024-01249-4","volume":"56","author":"M-H Kang","year":"2024","unstructured":"Kang M-H, Bae Y-S. IL-33 and IL-33-derived DC-based tumor immunotherapy. Exp Mol Med. 2024;56(6):1340\u20137.","journal-title":"Exp Mol Med"},{"issue":"Suppl 1","key":"15966_CR21","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.4103\/jcrt.jcrt_497_22","volume":"19","author":"SM Hadimani","year":"2023","unstructured":"Hadimani SM, Das S, Harish K. An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate\u2013an institutional study. J Cancer Res Ther. 2023;19(Suppl 1):S300\u20135.","journal-title":"J Cancer Res Ther"},{"issue":"6","key":"15966_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/ijgc-00009577-200311000-00018","volume":"13","author":"LEOND Lopez-Graniel","year":"2003","unstructured":"Lopez-Graniel LEOND, MENDIVIL C, VILCHIS M, Gomez G. Significance of microvascular density (MVD) in cervical cancer recurrence. Int J Gynecol Cancer. 2003;13(6):856\u201362.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"15966_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20070075","volume":"204","author":"L Arnold","year":"2007","unstructured":"Arnold L, Henry A, Poron F, Baba-Amer Y, Van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med. 2007;204(5):1057\u201369.","journal-title":"J Exp Med"},{"issue":"8","key":"15966_CR24","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","volume":"130","author":"KH Kraemer","year":"1994","unstructured":"Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018\u201321.","journal-title":"Arch Dermatol"},{"issue":"6","key":"15966_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1017\/S002193201400056X","volume":"47","author":"W Kelmemi","year":"2015","unstructured":"Kelmemi W, Chelly I, Kharrat M, Chaabouni-Bouhamed H. Consanguinity and homozygosity among Tunisian patients with an autosomal recessive disorder. J Biosoc Sci. 2015;47(6):718\u201326.","journal-title":"J Biosoc Sci"},{"issue":"3","key":"15966_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/jmg.2010.083022","volume":"48","author":"PT Bradford","year":"2011","unstructured":"Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011;48(3):168\u201376.","journal-title":"J Med Genet"},{"issue":"1","key":"15966_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ijd.13448","volume":"56","author":"C Naouali","year":"2017","unstructured":"Naouali C, Jones M, Nabouli I, Jerbi M, Tounsi H, Ben Rekaya M, et al. Epidemiological trends and clinicopathological features of cutaneous melanoma in sporadic and xeroderma pigmentosum Tunisian patients. Int J Dermatol. 2017;56(1):40\u20138.","journal-title":"Int J Dermatol"},{"issue":"7","key":"15966_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jnci\/djj103","volume":"98","author":"V Winnepenninckx","year":"2006","unstructured":"Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst. 2006;98(7):472\u201382.","journal-title":"J Natl Cancer Inst"},{"key":"15966_CR29","volume-title":"Xeroderma pigmentosum","author":"R Lucero","year":"2023","unstructured":"Lucero R, Horowitz D. Xeroderma pigmentosum. StatPearls: StatPearls publishing; 2023."},{"issue":"10","key":"15966_CR30","first-page":"1137","volume":"21","author":"S Jasper","year":"2023","unstructured":"Jasper S, Keim U, Leiter U, Amaral T, Flatz L, Forschner A. Prognosis in stage II melanoma of the head and neck depends on the histological subtype. JDDG: J der Deutschen Dermatologischen Gesellschaft. 2023;21(10):1137\u201346.","journal-title":"JDDG: J der Deutschen Dermatologischen Gesellschaft"},{"issue":"6","key":"15966_CR31","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4103\/idoj.IDOJ_778_20","volume":"12","author":"S Neema","year":"2021","unstructured":"Neema S, Kashif A, Kothari R. Melanoma in presence of xeroderma pigmentosum\u2013a difficult diagnosis. Indian Dermatology Online J. 2021;12(6):960\u20131.","journal-title":"Indian Dermatology Online J"},{"key":"15966_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","volume":"8","author":"G Genard","year":"2017","unstructured":"Genard G, Lucas S, Michiels C. Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo-and immunotherapies. Front Immunol. 2017;8:828.","journal-title":"Front Immunol"},{"issue":"20","key":"15966_CR33","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1200\/JCO.2008.19.9919","volume":"27","author":"TO Jensen","year":"2009","unstructured":"Jensen TO, Schmidt H, M\u00f8ller HJ, H\u00f8yer M, Maniecki MB, Sjoegren P, et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I\/II melanoma. J Clin Oncol. 2009;27(20):3330\u20137.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15966_CR34","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1002\/cncr.21283","volume":"104","author":"F Piras","year":"2005","unstructured":"Piras F, Colombari R, Minerba L, Murtas D, Floris C, Maxia C, et al. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D\u2010related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer: Interdisciplinary Int J Am Cancer Soc. 2005;104(6):1246\u201354.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"3","key":"15966_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/CMR.0000000000000352","volume":"27","author":"M Falleni","year":"2017","unstructured":"Falleni M, Savi F, Tosi D, Agape E, Cerri A, Moneghini L, et al. M1 and M2 macrophages\u2019 clinicopathological significance in cutaneous melanoma. Melanoma Res. 2017;27(3):200\u201310.","journal-title":"Melanoma Res"},{"issue":"3","key":"15966_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CMR.0000000000000522","volume":"29","author":"S Salmi","year":"2019","unstructured":"Salmi S, Siiskonen H, Sironen R, Tyynel\u00e4-Korhonen K, Hirschovits-Gerz B, Valkonen M, et al. The number and localization of CD68\u2009+\u2009and CD163\u2009+\u2009macrophages in different stages of cutaneous melanoma. Melanoma Res. 2019;29(3):237\u201347.","journal-title":"Melanoma Res"},{"issue":"6","key":"15966_CR37","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1182\/blood.V81.6.1607.1607","volume":"81","author":"Claire L Holness","year":"1993","unstructured":"Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. 1993. https:\/\/doi.org\/10.1182\/blood.V81.6.1607.1607.","journal-title":"Blood"},{"issue":"1","key":"15966_CR38","doi-asserted-by":"publisher","first-page":"7844","DOI":"10.1038\/s41598-022-11503-2","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li S, Liu F, Yang K. Role of CD68 in tumor immunity and prognosis prediction in pan-cancer. Sci Rep. 2022;12(1):7844.","journal-title":"Sci Rep"},{"issue":"1","key":"15966_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/imr.12223","volume":"262","author":"S Gordon","year":"2014","unstructured":"Gordon S, Pl\u00fcddemann A, Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev. 2014;262(1):36\u201355.","journal-title":"Immunol Rev"},{"issue":"6817","key":"15966_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/35051594","volume":"409","author":"M Kristiansen","year":"2001","unstructured":"Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman H-J, Law SA, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409(6817):198\u2013201.","journal-title":"Nature"},{"issue":"1","key":"15966_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cas.12314","volume":"105","author":"Y Komohara","year":"2014","unstructured":"Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 2014;105(1):1\u20138.","journal-title":"Cancer Sci"},{"key":"15966_CR42","doi-asserted-by":"publisher","unstructured":"Mathiesen H, Juul-Madsen K, Tramm T, Vorup-Jensen T, M\u00f8ller HJ, Etzerodt A et al. Prognostic value of CD163\u2009+\u2009macrophages in solid tumor malignancies: a scoping review. Immunol Lett. 2025:106970. https:\/\/doi.org\/10.1016\/j.imlet.2025.106970.","DOI":"10.1016\/j.imlet.2025.106970"},{"issue":"10","key":"15966_CR43","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41416-020-01037-7","volume":"123","author":"LF Tremble","year":"2020","unstructured":"Tremble LF, McCabe M, Walker SP, McCarthy S, Tynan RF, Beecher S, et al. Differential association of CD68(+) and CD163(+) macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma. Br J Cancer. 2020;123(10):1553\u201361.","journal-title":"Br J Cancer"},{"key":"15966_CR44","unstructured":"Knowles RG, Moncada S, editors. Nitric Oxide, mitochondria and cytotoxicity. Portland press proceedings. Portland press. 19980."},{"key":"15966_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7819-11-118","volume":"11","author":"S Korde Choudhari","year":"2013","unstructured":"Korde Choudhari S, Chaudhary M, Bagde S, Gadbail AR, Joshi V. Nitric oxide and cancer: a review. World J Surg Oncol. 2013;11:1\u201311.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"15966_CR46","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.3390\/ijms21061954","volume":"21","author":"S Khan","year":"2020","unstructured":"Khan S, Mittal S, McGee K, Alfaro-Munoz KD, Majd N, Balasubramaniyan V, et al. Role of neutrophils and myeloid-derived suppressor cells in glioma progression and treatment resistance. Int J Mol Sci. 2020;21(6):1954.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"15966_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.semcancer.2005.04.004","volume":"15","author":"Matthias Lechner","year":"2005","unstructured":"Lechner M, Lirk P, Rieder J, editors. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Seminars in cancer biology. Elsevier; 2005. https:\/\/doi.org\/10.1016\/j.semcancer.2005.04.004.","journal-title":"Seminars in cancer biology"},{"issue":"3","key":"15966_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/carcin\/bgt034","volume":"34","author":"AJ Burke","year":"2013","unstructured":"Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis. 2013;34(3):503\u201312.","journal-title":"Carcinogenesis"},{"key":"15966_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.redox.2015.08.009","volume":"6","author":"F Vannini","year":"2015","unstructured":"Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox Biol. 2015;6:334\u201343.","journal-title":"Redox Biol"},{"issue":"3","key":"15966_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5114\/pjp.2019.90399","volume":"70","author":"M Foks","year":"2019","unstructured":"Foks M, W\u0105growska-Danilewicz M, Danilewicz M, Bonczysta M, Olborski B, Stasikowska-Kanicka O. The number of CD163 positive macrophages is associatedwith more advanced skin melanomas, microvessels density and patient prognosis. Pol J Pathol. 2019;70(3):217\u201322.","journal-title":"Pol J Pathol"},{"issue":"2","key":"15966_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jso.27487","volume":"129","author":"Y Asai","year":"2024","unstructured":"Asai Y, Yanagawa N, Osakabe M, Yamada N, Sugimoto R, Sato A, et al. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma. J Surg Oncol. 2024;129(2):381\u201391.","journal-title":"J Surg Oncol"},{"issue":"3","key":"15966_CR52","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-2133.1991.tb14754.x","volume":"125","author":"A Anstey","year":"1991","unstructured":"Anstey A, Arlett C, Cole J, Norris P, Hamblin A, Limb G, et al. Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Br J Dermatol. 1991;125(3):272\u20138.","journal-title":"Br J Dermatol"},{"issue":"5","key":"15966_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/jmg.15.5.357","volume":"15","author":"HT Lynch","year":"1978","unstructured":"Lynch HT, Frichot B, Fisher J, Smith J, Lynch J. Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. J Med Genet. 1978;15(5):357\u201362.","journal-title":"J Med Genet"},{"issue":"8","key":"15966_CR54","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archdermatol.2009.87","volume":"145","author":"WH Green","year":"2009","unstructured":"Green WH, Wang SQ, Cognetta AB. Jr. Total-body cutaneous examination, total-body photography, and dermoscopy in the care of a patient with xeroderma pigmentosum and multiple melanomas. Arch Dermatol. 2009;145(8):910\u20135.","journal-title":"Arch Dermatol"},{"key":"15966_CR55","unstructured":"Fazaa B, Zghal M, Bailly C, Zeglaoui F, Goucha S, Mokhtar I, et al. editors. Melanoma in xeroderma pigmentosum: 12 cases. Annales de Dermatologie et de Venereologie; 2001."},{"issue":"4","key":"15966_CR56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1046\/j.1523-1747.2000.00093.x","volume":"115","author":"E Capulas","year":"2000","unstructured":"Capulas E, Lowe JE, Green MH, Arlett CF, Petit-Fr\u00e8re C, Clingen PH, et al. Ultraviolet-B-induced apoptosis and cytokine release in xeroderma pigmentosum keratinocytes. J Invest dermatology. 2000;115(4):687\u201393.","journal-title":"J Invest dermatology"},{"issue":"5","key":"15966_CR57","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1046\/j.0022-202x.2001.01525.x","volume":"117","author":"H Suzuki","year":"2001","unstructured":"Suzuki H, Kalair W, Shivji GM, Wang B, Toto P, Amerio P, et al. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts. J Invest dermatology. 2001;117(5):1151\u20135.","journal-title":"J Invest dermatology"},{"issue":"5","key":"15966_CR58","doi-asserted-by":"publisher","first-page":"557","DOI":"10.37349\/ei.2024.00159","volume":"4","author":"K Abid","year":"2024","unstructured":"Abid K, Bettaieb J, El Mezni F, Boussen H. Proinflammatory cytokines in xeroderma pigmentosum (XP) and non-XP cancer patients\u2014a pilot study. Explor Immunol. 2024;4(5):557\u201367.","journal-title":"Explor Immunol"},{"issue":"4","key":"15966_CR59","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jid.2020.11.012","volume":"141","author":"ER Rizza","year":"2021","unstructured":"Rizza ER, DiGiovanna JJ, Khan SG, Tamura D, Jeskey JD, Kraemer KH. Xeroderma pigmentosum: a model for human premature aging. J Invest Dermatology. 2021;141(4):976\u201384.","journal-title":"J Invest Dermatology"},{"issue":"21\u201322","key":"15966_CR60","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.cca.2010.07.006","volume":"411","author":"A Yadav","year":"2010","unstructured":"Yadav A, Saini V, Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta. 2010;411(21\u201322):1570\u20139.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"15966_CR61","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313\u201326.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"15966_CR62","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ajpath.2011.09.005","volume":"180","author":"Y Nakasone","year":"2012","unstructured":"Nakasone Y, Fujimoto M, Matsushita T, Hamaguchi Y, Huu DL, Yanaba M, et al. Host-derived MCP-1 and MIP-1\u03b1 regulate protective anti-tumor immunity to localized and metastatic B16 melanoma. Am J Pathol. 2012;180(1):365\u201374.","journal-title":"Am J Pathol"},{"issue":"11","key":"15966_CR63","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.4049\/jimmunol.166.11.6483","volume":"166","author":"M Nesbit","year":"2001","unstructured":"Nesbit M, Schaider H, Miller TH, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol. 2001;166(11):6483\u201390.","journal-title":"J Immunol"},{"issue":"4","key":"15966_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15(4):335\u201345.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"15966_CR65","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ni735","volume":"2","author":"RS Bystry","year":"2001","unstructured":"Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2001;2(12):1126\u201332.","journal-title":"Nat Immunol"},{"issue":"5","key":"15966_CR66","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1440-1711.2005.01365.x","volume":"83","author":"MC Lebre","year":"2005","unstructured":"Lebre MC, Burwell T, Vieira PL, Lora J, Coyle AJ, Kapsenberg ML, et al. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. Immunol Cell Biol. 2005;83(5):525\u201335.","journal-title":"Immunol Cell Biol"},{"issue":"7559","key":"15966_CR67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 2015;523(7559):231\u20135.","journal-title":"Nature"},{"issue":"2","key":"15966_CR68","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00005-012-0208-8","volume":"61","author":"S Sattler","year":"2013","unstructured":"Sattler S, Smits HH, Xu D, Huang FP. The evolutionary role of the IL-33\/ST2 system in host immune defence. Arch Immunol Ther Exp (Warsz). 2013;61(2):107\u201317.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"15966_CR69","doi-asserted-by":"publisher","first-page":"1533335","DOI":"10.3389\/fimmu.2025.1533335","volume":"16","author":"F Sheng","year":"2025","unstructured":"Sheng F, Li M, Yu J-M, Yang S-Y, Zou L, Yang G-J, et al. IL-33\/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Front Immunol. 2025;16:1533335.","journal-title":"Front Immunol"},{"key":"15966_CR70","doi-asserted-by":"publisher","first-page":"155961","DOI":"10.1016\/j.cyto.2022.155961","volume":"157","author":"WJ Yeoh","year":"2022","unstructured":"Yeoh WJ, Vu VP, Krebs P. IL-33 biology in cancer: an update and future perspectives. Cytokine. 2022;157:155961.","journal-title":"Cytokine"},{"key":"15966_CR71","doi-asserted-by":"publisher","first-page":"iv67","DOI":"10.1093\/annonc\/mdu326.31","volume":"25","author":"L Barrera","year":"2014","unstructured":"Barrera L, Arrieta O, Montes-Serv\u00edn E, Ram\u00edrez-Tirado L, Ba\u00f1ales-Mendez J, Salinas-Parra F. Data mining cytokines profile for prognosis in advanced non-small cell lung cancer. Ann Oncol. 2014;25:iv67.","journal-title":"Ann Oncol"},{"issue":"21","key":"15966_CR72","doi-asserted-by":"publisher","first-page":"2101029","DOI":"10.1002\/advs.202101029","volume":"8","author":"J Wu","year":"2021","unstructured":"Wu J, Chen Z, Wickstr\u00f6m SL, Gao J, He X, Jing X, et al. Interleukin-33 is a novel immunosuppressor that protects cancer cells from til killing by a macrophage-mediated shedding mechanism. Adv Sci. 2021;8(21):2101029.","journal-title":"Adv Sci"},{"issue":"1","key":"15966_CR73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4049\/jimmunol.1401344","volume":"194","author":"X Gao","year":"2015","unstructured":"Gao X, Wang X, Yang Q, Zhao X, Wen W, Li G, et al. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8\u2009+\u2009T and NK cells. J Immunol. 2015;194(1):438\u201345.","journal-title":"J Immunol"},{"issue":"6","key":"15966_CR74","doi-asserted-by":"publisher","first-page":"e1317420","DOI":"10.1080\/2162402X.2017.1317420","volume":"6","author":"V Lucarini","year":"2017","unstructured":"Lucarini V, Ziccheddu G, Macchia I, La Sorsa V, Peschiaroli F, Buccione C, et al. IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils. Oncoimmunology. 2017;6(6):e1317420.","journal-title":"Oncoimmunology"},{"issue":"5","key":"15966_CR75","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.18632\/aging.202531","volume":"13","author":"L Peng","year":"2021","unstructured":"Peng L, Sun W, Wei F, Chen L, Wen W. Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way. Aging. 2021;13(5):6740\u201351.","journal-title":"Aging"},{"issue":"2","key":"15966_CR76","doi-asserted-by":"publisher","first-page":"e1003918","DOI":"10.1371\/journal.ppat.1003918","volume":"10","author":"C Li","year":"2014","unstructured":"Li C, Li H, Jiang Z, Zhang T, Wang Y, Li Z, et al. Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin. PLoS Pathog. 2014;10(2):e1003918.","journal-title":"PLoS Pathog"},{"key":"15966_CR77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.anndiagpath.2017.01.006","volume":"27","author":"EM Saied","year":"2017","unstructured":"Saied EM, El-Etreby NM. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours. Annals Diagn Pathol. 2017;27:62\u20138.","journal-title":"Annals Diagn Pathol"},{"issue":"1","key":"15966_CR78","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/jid.2008.205","volume":"129","author":"DG Uffort","year":"2009","unstructured":"Uffort DG, Grimm EA, Ellerhorst JA. NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma. J Invest Dermatol. 2009;129(1):148\u201354.","journal-title":"J Invest Dermatol"},{"key":"15966_CR79","doi-asserted-by":"publisher","first-page":"e360501","DOI":"10.1590\/acb360501","volume":"36","author":"J Ke","year":"2021","unstructured":"Ke J, Cai G. Effect of IL-33 on pyroptosis of macrophages in mice with sepsis via NF-\u03baB\/p38 MAPK signaling pathway. Acta Cir\u00fargica Brasileira. 2021;36:e360501.","journal-title":"Acta Cir\u00fargica Brasileira"},{"issue":"2","key":"15966_CR80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12032-016-0880-3","volume":"34","author":"Y Fang","year":"2017","unstructured":"Fang Y, Zhao L, Xiao H, Cook KM, Bai Q, Herrick EJ, et al. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer. Med Oncol. 2017;34(2):23.","journal-title":"Med Oncol"},{"issue":"1","key":"15966_CR81","first-page":"769","volume":"16","author":"X Chen","year":"2018","unstructured":"Chen X, Lu K, Timko NJ, Weir DM, Zhu Z, Qin C, et al. IL-33 notably inhibits the growth of colon cancer cells. Oncol Lett. 2018;16(1):769\u201374.","journal-title":"Oncol Lett"},{"issue":"9","key":"15966_CR82","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms19092676","volume":"19","author":"KM Larsen","year":"2018","unstructured":"Larsen KM, Minaya MK, Vaish V, Pe\u00f1a MMO. The Role of IL-33\/ST2 Pathway in Tumorigenesis. Int J Mol Sci. 2018;19(9):2676.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"15966_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/imm.13125","volume":"159","author":"MC Nielsen","year":"2020","unstructured":"Nielsen MC, Andersen MN, M\u00f8ller HJ. Monocyte isolation techniques significantly impact the phenotype of both isolated monocytes and derived macrophages in vitro. Immunology. 2020;159(1):63\u201374.","journal-title":"Immunology"},{"issue":"3","key":"15966_CR84","doi-asserted-by":"publisher","first-page":"e0265196","DOI":"10.1371\/journal.pone.0265196","volume":"17","author":"D Unuvar Purcu","year":"2022","unstructured":"Unuvar Purcu D, Korkmaz A, Gunalp S, Helvaci DG, Erdal Y, Dogan Y, et al. Effect of stimulation time on the expression of human macrophage polarization markers. PLoS ONE. 2022;17(3):e0265196.","journal-title":"PLoS ONE"},{"issue":"1","key":"15966_CR85","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/ncomms16041","volume":"8","author":"K Buscher","year":"2017","unstructured":"Buscher K, Ehinger E, Gupta P, Pramod AB, Wolf D, Tweet G, et al. Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival. Nat Commun. 2017;8(1):16041.","journal-title":"Nat Commun"},{"issue":"2","key":"15966_CR86","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","volume":"69","author":"Y Liu","year":"1997","unstructured":"Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4, 5\u2010dimethylthiazol\u20102\u2010yl)\u20102, 5\u2010diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997;69(2):581\u201393.","journal-title":"J Neurochem"},{"issue":"3","key":"15966_CR87","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/eji.200939889","volume":"40","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol. 2010;40(3):824\u201335.","journal-title":"Eur J Immunol"},{"key":"15966_CR88","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.biopha.2018.06.126","volume":"106","author":"W Song","year":"2018","unstructured":"Song W, Thakor P, Vesey DA, Gobe GC, Morais C. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells. Biomed Pharmacother. 2018;106:247\u201354.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"15966_CR89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/ijo.2013.2203","volume":"44","author":"A Engstr\u00f6m","year":"2014","unstructured":"Engstr\u00f6m A, Erlandsson A, Delbro D, Wijkander J. Conditioned media from macrophages of M1, but not M2 phenotype, inhibit the proliferation of the colon cancer cell lines HT-29 and CACO-2. Int J Oncol. 2014;44(2):385\u201392.","journal-title":"Int J Oncol"},{"issue":"11","key":"15966_CR90","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.jid.2022.04.024","volume":"142","author":"K Kainulainen","year":"2022","unstructured":"Kainulainen K, Takabe P, Heikkinen S, Aaltonen N, de la Motte C, Rauhala L, et al. M1 macrophages induce protumor inflammation in melanoma cells through TNFR\u2013NF-\u03baB signaling. J Invest Dermatology. 2022;142(11):3041\u201351. e10.","journal-title":"J Invest Dermatology"},{"key":"15966_CR91","doi-asserted-by":"publisher","first-page":"103792","DOI":"10.1016\/j.pdpdt.2023.103792","volume":"44","author":"AH Soliman","year":"2023","unstructured":"Soliman AH, Youness RA, Sebak AA, Handoussa H. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis. Photodiagn Photodyn Ther. 2023;44:103792.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"1","key":"15966_CR92","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/s41467-019-10182-4","volume":"10","author":"R Mnatsakanyan","year":"2019","unstructured":"Mnatsakanyan R, Markoutsa S, Walbrunn K, Roos A, Verhelst SH, Zahedi RP. Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019;10(1):2195.","journal-title":"Nat Commun"},{"issue":"30","key":"15966_CR93","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.3748\/wjg.v11.i30.4644","volume":"11","author":"S Pinlaor","year":"2005","unstructured":"Pinlaor S, Sripa B, Ma N, Hiraku Y, Yongvanit P, Wongkham S, et al. Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J Gastroenterology: WJG. 2005;11(30):4644.","journal-title":"World J Gastroenterology: WJG"},{"issue":"5","key":"15966_CR94","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3390\/cancers15051619","volume":"15","author":"Y Xu","year":"2023","unstructured":"Xu Y, Nowsheen S, Deng M. DNA repair deficiency regulates immunity response in cancers: molecular mechanism and approaches for combining immunotherapy. Cancers. 2023;15(5):1619.","journal-title":"Cancers"},{"issue":"7","key":"15966_CR95","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/1078-0432.CCR-20-3322","volume":"27","author":"S Topka","year":"2021","unstructured":"Topka S, Steinsnyder Z, Ravichandran V, Tkachuk K, Kemel Y, Bandlamudi C, et al. Targeting germline-and tumor-associated nucleotide excision repair defects in cancer. Clin Cancer Res. 2021;27(7):1997\u20132010.","journal-title":"Clin Cancer Res"},{"key":"15966_CR96","unstructured":"Chelakkot VS, Thomas K, Romigh T, Bernat A, Samuel R, Goli N et al. XPC loss-of-function triggers melanomagenesis through <\u2009em>CDKN2A downregulation. bioRxiv. 2025;2025:646637."},{"issue":"1","key":"15966_CR97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5301\/jbm.5000186","volume":"31","author":"M Zafeer","year":"2016","unstructured":"Zafeer M, Mahjabeen I, Kayani MA. Increased expression of ERCC2 gene in head and neck cancer is associated with aggressive tumors: a systematic review and case-control study. Int J Biol Mark. 2016;31(1):17\u201325.","journal-title":"Int J Biol Mark"},{"issue":"11","key":"15966_CR98","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/cncr.21031","volume":"103","author":"EV Stevens","year":"2005","unstructured":"Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope\u2019 CG, Kohn EC, et al. Expression of xeroderma pigmentosum a protein predicts improved outcome in metastatic ovarian carcinoma. Cancer: Interdisciplinary Int J Am Cancer Soc. 2005;103(11):2313\u20139.","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"4","key":"15966_CR99","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/ijgc-00009577-200807000-00014","volume":"18","author":"KD Steffensen","year":"2008","unstructured":"Steffensen KD, Waldstr\u00f8m M, Jeppesen U, Brandslund I, Jakobsen A. Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer. Int J Gynecol Cancer. 2008;18(4):702\u201310.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"15966_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2024.06.004","volume":"115","author":"C Takemori","year":"2024","unstructured":"Takemori C, Koyanagi-Aoi M, Fukumoto T, Kunisada M, Wakamatsu K, Ito S, et al. Revealing the UV response of melanocytes in xeroderma pigmentosum group A using patient-derived induced pluripotent stem cells. J Dermatol Sci. 2024;115(3):111\u201320.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"15966_CR101","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.18632\/oncotarget.27966","volume":"12","author":"M Rubatto","year":"2021","unstructured":"Rubatto M, Merli M, Avallone G, Agostini A, Mastorino L, Caliendo V, et al. Immunotherapy in xeroderma pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review. Oncotarget. 2021;12(11):1116\u201321.","journal-title":"Oncotarget"},{"key":"15966_CR102","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fimmu.2018.00424","volume":"9","author":"G B\u00e9ke","year":"2018","unstructured":"B\u00e9ke G, Dajnoki Z, Kapit\u00e1ny A, G\u00e1sp\u00e1r K, Medgyesi B, P\u00f3liska S, et al. Immunotopographical differences of human skin. Front Immunol. 2018;9:424.","journal-title":"Front Immunol"},{"issue":"4","key":"15966_CR103","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/php.14117","volume":"101","author":"N Garimano","year":"2025","unstructured":"Garimano N, Aguayo Fr\u00edas T, Gonz\u00e1lez Maglio DH. Beyond ultraviolet radiation: immune system modulation through skin exposure to visible light and infrared radiation. Photochem Photobiol. 2025;101(4):846\u201357.","journal-title":"Photochem Photobiol"},{"issue":"13","key":"15966_CR104","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.3390\/ijms26135992","volume":"26","author":"A Chikhaoui","year":"2025","unstructured":"Chikhaoui A, Najjar D, Bouchoucha S, Boussetta R, Achour NB, Tizaoui K, et al. Profiles of monocyte subsets and fibrosis-related genes in patients with muscular dystrophy undergoing intermittent prednisone therapy. Int J Mol Sci. 2025;26(13):5992.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15966-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:09:46Z","timestamp":1779250186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15966-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15966"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15966-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Helsinki principles and approved by Institute Pasteur Ethics Committee in Tunisia under the ethical accord number PCI\/22\/2012v2. All participants have given their written consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have given their consent to publish the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}